Contrary to adult patients, expression of the multidrug resistance gene (MDR1) fails to define a poor prognostic group in childhood AML
- 1 February 2003
- journal article
- Published by Springer Nature in Leukemia
- Vol. 17 (2) , 470-471
- https://doi.org/10.1038/sj.leu.2402806
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- BCRP gene expression is associated with a poor response to remission induction therapy in childhood acute myeloid leukemiaLeukemia, 2002
- Benefit of cyclosporine modulation of drug resistance in patients with poor-risk acute myeloid leukemia: a Southwest Oncology Group studyBlood, 2001
- Clinical relevance of in vitro chemoresistance in childhood acute myeloid leukemiaLeukemia, 2001
- Drug resistance in hematologic malignanciesCurrent Opinion in Oncology, 2001
- Mitoxantrone, Etoposide, and Cyclosporine Therapy in Pediatric Patients With Recurrent or Refractory Acute Myeloid LeukemiaJournal of Clinical Oncology, 2000
- Quantitative assessment of retroviral transfer of the human multidrug resistance 1 gene to human mobilized peripheral blood progenitor cells engrafted in nonobese diabetic/severe combined immunodeficient miceBlood, 2000
- Relationship Between Major Vault Protein/Lung Resistance Protein, Multidrug Resistance-Associated Protein, P-Glycoprotein Expression, and Drug Resistance in Childhood LeukemiaBlood, 1998